General MedicationsINTRAVENOUSStandard
NEOSTIGMINE METHYLSULFATE
NEOSTIGMINE METHYLSULFATE
Standard Dose
3MG/3ML (1MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview NEOSTIGMINE METHYLSULFATE is listed in Drugs@FDA under application 216291 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient NEOSTIGMINE METHYLSULFATE Form and strength SOLUTION;INTRAVENOUS - 3MG/3ML (1MG/ML) Sponsor DR REDDYS Submission history Latest submission status date: 2022-07-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview NEOSTIGMINE METHYLSULFATE is listed in Drugs@FDA under application 216291 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NEOSTIGMINE METHYLSULFATE Form and strength SOLUTION;INTRAVENOUS - 3MG/3ML (1MG/ML) Sponsor DR REDDYS Submission history Latest submission status date: 2022-07-06 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.